Capricor Therapeutics (CAPR) EBITDA Margin Growth (5y) (2016 - 2024)
Capricor Therapeutics (CAPR) EBITDA Margin Growth (5y) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Capricor Therapeutics | 404.05 Mn | 404.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 59,874.00 |
| Sep 30, 2024 | 57,043.00 |
| Jun 30, 2024 | 21,153.00 |
| Mar 31, 2024 | 100,672.00 |
| Dec 31, 2023 | 49,952.00 |
| Sep 30, 2023 | 179,185.00 |
| Jun 30, 2023 | 83,279.00 |
| Mar 31, 2023 | 64,735.00 |
| Dec 31, 2022 | -15,087.00 |
| Sep 30, 2022 | 43,499.00 |
| Jun 30, 2021 | -37,847.00 |
| Mar 31, 2021 | -1.23 Mn |
| Dec 31, 2020 | -710,520.00 |
| Sep 30, 2020 | -2.25 Mn |
| Jun 30, 2020 | -665,881.00 |
| Mar 31, 2020 | -94,395.00 |
| Dec 31, 2019 | -62,011.00 |
| Sep 30, 2019 | -100,310.00 |
| Jun 30, 2019 | -36,127.00 |
| Dec 31, 2017 | -69,066.00 |